Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand-Factor

This publication has 9 references indexed in Scilit:

• Bernard-Soulier syndrome in two Swedish families: Effect of DDAVP on bleeding time
  European Journal of Haematology, 2009
• DDAVP—The Multipotent Drug in Patients With Coagulopathies
  Transfusion Medicine Reviews, 1991
• Use of DDAVP in inherited and acquired platelet dysfunction
  American Journal of Hematology, 1990
• Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders.
  1988
• Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders [see comments]
  Blood, 1988
• DDAVP in Bernard-Soulier syndrome
  Thrombosis Research, 1988
• DDAVP shortens the bleeding time in bernard-soulier syndrome
  Thrombosis Research, 1988
• Competitive Enzyme‐Linked Immunoassay for the Quantitation of Platelet‐Associated Immunoglobulins (IgG, IgM, IgA) and Complement (C3c, C3d) with Polyclonal and Monoclonal Reagents¹
  Vox Sanguinis, 1987
• Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis.
  Journal of Clinical Investigation, 1982